Companies: 10,795·Total market cap: $144.5T
Immuron Limited

Immuron Limited

IMRNNASDAQHealthcare● Active
$1.15
$-0.05(-4.17%)
Market Cap$7412561
P/E Ratio
52W High$2.39
52W Low$0.677
Overview
Foreign Private Issuer · Files 20-F / 6-K

Immuron Limited (IMRN) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001660046 · IMRN · NASDAQ · as of Jun 9, 2026

Filing snapshot

405
Total Filings
6-K
Latest Form
2026-05-28
Most Recent
2017
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001660046 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2025-09-25
Fiscal Year End
Sep 25, 2025
Accession No.
0001213900-25-091414
Primary Document
ea0245648-20f_immuron.htm
Source: data.sec.gov · CIK 0001660046 · Accession 0001213900-25-091414

Latest Key Filings

6-KQuarterly Report
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-28
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-28
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-05-14
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-05-14
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-08
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-05-04
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-30
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-29
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-29
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-29
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-29
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-29
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-17
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-13
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-03-05
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-03-02
View
Showing 1–15 of 405 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001660046  |  Exchange: NASDAQ · Healthcare

Immuron Limited (NASDAQ: IMRN) has submitted 405 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2017. As a Healthcare sector company with CIK 0001660046, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Immuron Limited's most comprehensive regulatory disclosure. The most recent Immuron Limited 10-K was filed on 2025-09-25 for fiscal year ending 2025. Historical IMRN 10-K annual reports are available from 2016 through 2025.

Investors researching Immuron Limited SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09

Frequently Asked Questions

IMRN SEC Filings · 8 questions

Immuron Limited (IMRN) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 405 filings and access original documents at no cost. Immuron Limited's CIK is 0001660046.

IMRN SEC filingsImmuron Limited SEC documentsfind IMRN 10-K